ULY vs. BIAF

Last updated Jun 4, 2026

ULY (Urgent.ly Inc. Common Stock) and BIAF (bioAffinity Technologies Inc.) are both stocks. ULY operates in Software - Application (Technology), while BIAF operates in Diagnostics & Research (Healthcare). Over the past year, ULY returned -4.61% vs -80.07% for BIAF. At a 0.05 correlation, their price movements are largely independent.

Performance

ULY vs. BIAF - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Urgent.ly Inc. Common Stock (ULY) and bioAffinity Technologies Inc. (BIAF). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ULY achieves a 84.25% return, which is significantly higher than BIAF's 43.22% return.

ULY

• 1D: 0.00%
• 1M: 0.00%
• YTD: 84.25%
• 6M: 199.72%
• 1Y: -4.61%
• 3Y*: —
• 5Y*: —
• 10Y*: —

BIAF

• 1D: 0.60%
• 1M: -22.48%
• YTD: 43.22%
• 6M: 7.64%
• 1Y: -80.07%
• 3Y*: -68.60%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ULY vs. BIAF - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
ULY Urgent.ly Inc. Common Stock	84.25%	-52.29%	-83.91%	-44.47%
BIAF bioAffinity Technologies Inc.	43.22%	-95.68%	-38.12%	8.93%

Correlation

The correlation between ULY and BIAF is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.16
Correlation (All Time) Calculated using the full available price history since Oct 20, 2023	0.05

The correlation between ULY and BIAF shifts across timeframes, from 0.05 (all time) to 0.16 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap ULY : $11.34M BIAF : $7.60M
EPS ULY : -$13.78 BIAF : -$7.86
PS Ratio ULY : 0.06 BIAF : 0.60
Total Revenue (TTM) ULY : $129.19M BIAF : $5.66M
Gross Profit (TTM) ULY : $31.48M BIAF : $944.59K
EBITDA (TTM) ULY : -$4.02M BIAF : -$15.35M

Return for Risk

ULY vs. BIAF — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ULY

ULY Risk / Return Rank: 54
ULY Sharpe Ratio Rank: 41
ULY Sortino Ratio Rank: 77
ULY Omega Ratio Rank: 74
ULY Calmar Ratio Rank: 39
ULY Martin Ratio Rank: 39

BIAF

BIAF Risk / Return Rank: 22
BIAF Sharpe Ratio Rank: 24
BIAF Sortino Ratio Rank: 31
BIAF Omega Ratio Rank: 30
BIAF Calmar Ratio Rank: 8
BIAF Martin Ratio Rank: 16

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ULY vs. BIAF - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Urgent.ly Inc. Common Stock (ULY) and bioAffinity Technologies Inc. (BIAF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ULY	BIAF	Difference
Sharpe ratio Return per unit of total volatility	-0.02	-0.41	+0.38
Sortino ratio Return per unit of downside risk	2.10	0.01	+2.09
Omega ratio Gain probability vs. loss probability	1.25	1.00	+0.25
Calmar ratio Return relative to maximum drawdown	-0.06	-0.86	+0.80
Martin ratio Return relative to average drawdown	-0.08	-1.15	+1.07
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ULY vs. BIAF - Sharpe Ratio Comparison

The current ULY Sharpe Ratio is -0.02, which is higher than the BIAF Sharpe Ratio of -0.41. The chart below compares the historical Sharpe Ratios of ULY and BIAF, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ULY	BIAF	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.02	-0.41	+0.38
Sharpe Ratio (All Time) Calculated using the full available price history	-0.36	-0.33	-0.03

Drawdowns

ULY vs. BIAF - Drawdown Comparison

The maximum ULY drawdown since its inception was -97.43%, roughly equal to the maximum BIAF drawdown of -99.70%. Use the drawdown chart below to compare losses from any high point for ULY and BIAF.

Drawdown Indicators

	ULY	BIAF	Difference
Max Drawdown Largest peak-to-trough decline	-97.43%	-99.70%	+2.27%
Max Drawdown (1Y) Largest decline over 1 year	-80.36%	-93.15%	+12.79%
Max Drawdown (3Y) Largest decline over 3 years	—	-99.17%	—
Current Drawdown Current decline from peak	-92.15%	-99.32%	+7.17%
Average Drawdown Average peak-to-trough decline	-81.52%	-84.32%	+2.80%
Ulcer Index Depth and duration of drawdowns from previous peaks	57.44%	69.54%	-12.10%

Volatility

ULY vs. BIAF - Volatility Comparison

The current volatility for Urgent.ly Inc. Common Stock (ULY) is 0.00%, while bioAffinity Technologies Inc. (BIAF) has a volatility of 20.63%. This indicates that ULY experiences smaller price fluctuations and is considered to be less risky than BIAF based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ULY	BIAF	Difference
Volatility (1M) Calculated over the trailing 1-month period	0.00%	20.63%	-20.63%
Volatility (6M) Calculated over the trailing 6-month period	122.35%	127.57%	-5.22%
Volatility (1Y) Calculated over the trailing 1-year period	212.55%	197.19%	+15.36%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	173.53%	223.77%	-50.24%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	173.53%	223.77%	-50.24%

Dividends

ULY vs. BIAF - Dividend Comparison

Neither ULY nor BIAF has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ULY and BIAF in my portfolio?

ULY and BIAF have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ULY or BIAF?

BIAF has higher volatility (20.63%) compared to ULY (0.00%). In terms of maximum drawdown, ULY dropped -97.43% vs BIAF's -99.70%.

Which has better risk-adjusted returns?

ULY currently has the higher Sharpe Ratio (-0.02 vs -0.41), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.